Rinvoq: Common Side Effects You Should Know

Rinvoq (upadacitinib) is a prescribed medication used to treat rheumatoid arthritis and psoriatic arthritis. It is a Janus kinase (JAK) inhibitor that helps reduce inflammation, pain, and disability by blocking proteins involved in the body’s inflammatory response. While effective in reducing signs and symptoms of rheumatoid arthritis and psoriatic arthritis, Rinvoq is also associated with certain common side effects that it’s users should be aware of.

The most commonly reported side effects associated with Rinvoq include difficulty breathing, cough, upper respiratory infections, high cholesterol levels, skin rash, headache, nausea, and redness and pain at the site of the injection. Additionally, patients with rheumatoid arthritis treated with Rinvoq may face an increased risk of infection, cancer, and blood clots, as well as unwanted changes in blood panels and increases in liver enzymes.

It’s important for users of Rinvoq to be aware of the common side effects that may come with use of the medication. If patients experience any serious or worrisome side effects, they should reach out to their healthcare provider and inform them of any potential issues they may be experiencing.

Rinvoq may not be the right medication for everyone and needs to be considered on an individual basis. Speaking with a healthcare provider is the best way to determine whether Rinvoq is an appropriate treatment option. Additionally, patients should also inform their healthcare provider of any pre-existing conditions, any current medications they may be taking, and any potential allergies prior to starting Rinvoq so that potential side effects and conflicts can be ruled out.

If you are considering Rinvoq as a treatment for your condition, it’s important to speak with a healthcare provider to determine whether the potential benefits outweigh the potential risks, and to understand what common side effects you may encounter with the use of this medication.